As a result [of the NCG's comprehensive negotiation process with pharma companies], we secured remarkable discounts ranging from 23 percent to an incredible 99 percent off…
In Conversation
My role encompasses not only overseeing the strategic growth of the Asian Cancer Institutes but also navigating the complex healthcare landscape in India. The journey involves…
While crucial, Ayushman Bharat is not a standalone solution. India’s strategy should involve a comprehensive approach, including an increase in the overall healthcare budget
In essence, the opportunity lies in aligning chemical production with eco-friendly practices, meeting the sustainability criteria set by major markets. This not only addresses current environmental…
The delicate equilibrium sought by the government, balancing healthcare accessibility, fostering innovation, and promoting value-driven pharmaceutical development, is evident
Our aim is not to become as large as the IQVIAs or Parexels of this world, but to remain a mid-sized CRO that is as global…
Given that seven out of ten prescriptions in Europe are for generics, it is in everybody’s interest to have a thriving generic industry
The regulation surrounding cannabis in Portugal has become notably favourable, creating a conducive environment for exploration in this sector
The focus is on expanding the market itself rather than gaining market share
The strategic move to more complex developments and the emphasis on disruptive and innovative areas showcase Tecnimede's commitment to staying at the forefront of pharmaceutical advancements
We are extremely proud of our ability to ‘turn rocks into diamonds’, which in essence is commercial excellence in action
Leading Indian manufacturers are redefining their roles in global supply chains.
